BIOCRYST PHARMACEUTICALS INC
BCRX·09058V103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BCRX (BIOCRYST PHARMACEUTICALS INC) is held by 154 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($215.6M), RA CAPITAL MANAGEMENT, L.P. ($150.7M), STATE STREET CORP ($116.2M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 98 funds bought BCRX.
154
Holders
(17 Elite)
$1.6B
Total Value
62% (159)
Consensus
98 buying - 61 selling
13F: Insider & Congress:
Who's Trading
InsiderHTHEGGIE THERESASell $505KMar 20, 2026
InsiderBPBarnes Alane PSell $1.4MMar 16, 2026
ActivistDMDeerfield Mgmt, L.P.6.8%Feb 12, 2026
InsiderBPBarnes Alane PSell $167KDec 22, 2025
InsiderBPBarnes Alane PSell $162KDec 15, 2025
InsiderSMSANDERS MACHELLESell $69KNov 13, 2025
Showing 1-20 of 168
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer